Prof. Wang was the founding Executive Dean of Academy of Pharmacy. He earned his PhD in Bio-Organic Chemistry from Washington University in St. Louis, Missouri, USA, and was an NIH/NRSA postdoctoral fellow studying mechanisms of DNA repair in mammalian system. Before joining XJTLU, he was a tenured faculty member in the Department of Biochemistry and Molecular Biology at Indiana University School of Medicine (IUSM), USA. He joined the faculty of Indiana University School of Medicine in 2001 as the Scientific Director of a newly established Proteomics Core. In 2004, he spearheaded a biotech CRO, Monarch Life Sciences, and served as Executive VP of Research until 2010. He also served as the director of Protein Analysis Research Center at IUSM from 2001 to 2016. His research centers around biomarkers and drug target discovery, and deciphering the protein interaction networks in complex human diseases such as cancer with the use of high throughput proteomics technologies such as quantitative mass spectrometry platforms. Additionally, he also has expertise in mammalian DNA repair and macro-molecular interaction studies using surface plasmon resonance (SPR) analysis. He has collaborated with more than 100 basic and clinical investigators both across the United States and internationally to advance knowledge related to human health. He has supervised more than 60 graduate students, postdoctoral fellows, and research associates. He was also a Co-Principal Investigator on the U.S. National Cancer Institute’s Clinical Proteomics Technologies Application for Cancer (CPTAC) Program. He received a number of awards including a Young Investigator’s Award in 2004 HUPO meeting. He has published more than 100 peer-reviewed articles in DNA repair, biochemistry, and proteomics related journals and book chapters, and served as an expert reviewer for many high-impact journals as well as NIH and the U.S. Department of Defense grant applications.

Pathogenesis of Parkinsons Disease

Molecular Mechanisms of Drug Resistance in Cancer and Biomarker Development for Cisplatin Resistance in Human Ovarian Cancer

Targeting Alterred Pyruvate Metabolism for Prostate Cancer Therapy

Development of New Strategies/Methodologies in Proteomics/Metabolomics and Their Applications in Biomedical Research

Biomarker Clinical Applications

Executive Dean Professor, Academy of Pharmacy, Xian Jiaotong-Liverpool University, Suzhou, China, 2020-2023

Head of Department, Department of Biological Sciences, Xian Jiaotong-Liverpool University, Suzhou, China, 2018-2022

Tenured Associate Professor, Biochemistry Molecular Biology, Indiana University School of Medicine, Indianapolis, Indiana, USA – 2010-2018

Tenure-track Assistant Professor, Biochemistry Molecular Biology, Indiana University School of Medicine, Indianapolis, Indiana, USA – 2004-2010

Assistant Scientist, Assistant Professor (part-time), Biochemistry Molecular Biology, Indiana University School of Medicine, Indianapolis, Indiana, USA – 2001-2004

Director of Proteomics, Indiana University School of Medicine, Indianapolis, Indiana, USA – 2001-2016

Vice President of Research Development, Monarch Life Sciences, Indianapolis, Indiana, USA – 2004-2010

NIH/NSRA Postdoctoral Fellow, Indiana University School of Medicine, Indianapolis, Indiana, USA – 1998-2001

BIO312 Protein Structure and Function

BIO108 Organic Chemistry for Biologists

BIO401 Research Methods in Biotechnology

APH001

APH404

BIO312

BIO401

Guest on “Sound Medicine” radio interview, USA, 2007

Guest on the journal “Proteomics” webcast – Cisplatin resistance of ovarian cancer, 2006

Interview Guest on World Talk Radio (San Francisco) – Science Society, USA

Young Investigator Award, International Human Proteome Organization, 2004

Invited Guest Speaker, American Broadcasting Company (ABC)’s Webcast on Proteomics as a new tool for biomedical sciences, USA

Individual National Research Service Award (F32), National Institutes of Health (NIH), USA